Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 12/02 11:30:00 am
7943 GBX   +1.83%
11:18aWho, when and how? A look at the UK's vaccination rollout
AQ
11:05aHow the U.K. Beat the U.S. and Europe to a Covid-19 Vaccine
DJ
09:29aASTRAZENECA : Crestor to be divested to Grunenthal in Europe
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by treatment area as follows:

- oncology (36.8%);

- respiratory diseases (22.9%);

- cardiovascular, renal and metabolic diseases (18.6%);

- other (21.7%): inflammatory and autoimmune diseases, neurological diseases, gastrointestinal and infectious diseases.

Net sales are distributed geographically as follows: the United Kingdom (2%), Continental Europe (16.5%), Americas (38.3%) and Africa/Asia/Australia (43.2%).

Number of employees : 70 600 people.
Sales per Business
20182019Delta
GBP (in Million)%GBP (in Million)%
Oncology4,52127.3%6,79435.5% +50.28%
Cardiovascular, Renal & Metabolism5,03230.4%5,41328.3% +7.57%
Respiratory3,68322.2%4,22622.1% +14.74%
Other Diseases2,55015.4%2,03910.7% -20.04%
Externalisation Revenue780.714.7%641.983.4% -17.77%
Sales per region
2019
GBP (in Million)%
United States6,30833%
China3,81520%
Japan1,97710.3%
United Kingdom1,4287.5%
Other Asia, Africa and Australasia1,1125.8%
Other Continental Europe1,0125.3%
Sweden653.743.4%
Other Americas638.063.3%
Germany551.842.9%
France453.072.4%
Managers
NameAgeSinceTitle
Pascal Soriot602012Chief Executive Officer & Executive Director
Leif Johansson682012Non-Executive Chairman
Pam Cheng482015Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer682013Chief Financial Officer & Executive Director
Menelas N. Pangalos, Dr.-2019EVP-Biopharmaceuticals Research & Development
José Baselga, Dr.60-Executive VP-Oncology Research & Development
Henry D. Cremisi, Dr.--Medical Director
Marcus Wallenberg631999Independent Non-Executive Director
Graham Chipchase562019Senior Independent Non-Executive Director
Geneviéve B. Berger, Dr.642012Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,312,307,462 1,256,516,741 95.7% 0 0.0% 95.7%
Shareholders
NameEquities%
Investor AB (Investment Company) 51,587,810 3.93%
BlackRock Investment Management (UK) Ltd. 42,170,900 3.21%
Capital Research & Management Co. (World Investors) 41,526,368 3.16%
The Vanguard Group, Inc. 39,268,235 2.99%
Wellington Management Co. LLP 38,725,550 2.95%
Norges Bank Investment Management 31,032,000 2.36%
BlackRock Fund Advisors 24,835,517 1.89%
Legal & General Investment Management Ltd. 24,626,000 1.88%
Fidelity Management & Research Co. LLC 17,532,022 1.34%
BlackRock Advisors (UK) Ltd. 17,103,169 1.30%
Holdings
NameEquities%Valuation
AstraZeneca Pharma India Limited (506820) 18,750,00075.0%1,088,667,750 USD
Viela Bio, Inc. (VIE) 14,650,33426.8%467,492,158 USD
ADC Therapeutics SA (ADCT) 3,811,2154.97%109,343,758 USD
Innate Pharma (IPH) 7,485,5009.48%29,663,689 USD
Circassia Group Plc (CIR) 71,081,21717.9%19,897,765 USD
PhaseBio Pharmaceuticals, Inc. (PHAS) 3,004,55410.2%8,202,432 USD
Entasis Therapeutics Holdings Inc. (ETTX) 2,164,8556.10%3,485,417 USD
Markets and indexes
-
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, NASDAQ OMX Nordic 120, OMX Nordic 40, OMX Stockholm 30, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  AZN:LN
- Reuters Code :  AZN.L
- Datastream Code :  AZN
Company contact information
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA Cambridge, Cambridgeshire


Phone : +44 (0)20 3749 5000
Fax : +44 (0)20 7604 8151
web site : http://www.astrazeneca.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of AstraZeneca PLC
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ASTRAZENECA PLC6.18%137 451
JOHNSON & JOHNSON1.08%388 168
ROCHE HOLDING AG-4.59%284 650
PFIZER, INC.6.17%219 056
MERCK & CO., INC.-10.34%206 324
NOVARTIS AG-11.46%205 415
ABBVIE INC.17.51%183 680
NOVO NORDISK A/S7.85%156 152
BRISTOL-MYERS SQUIBB COMPANY-2.77%141 031
ELI LILLY AND COMPANY10.75%131 962
AMGEN INC.-6.63%131 035
SANOFI-6.16%127 364
GLAXOSMITHKLINE PLC-22.37%92 309
CHUGAI PHARMACEUTICAL CO., LTD.49.08%78 894
JIANGSU HENGRUI MEDICINE CO., LTD.20.12%70 444
DAIICHI SANKYO COMPANY, LIMITED52.32%68 197
BAYER AG-33.15%57 642
TAKEDA PHARMACEUTICAL COMPANY LIMITED-13.87%55 889
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED41.12%27 907
ASTELLAS PHARMA INC.-19.71%26 723
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.70.75%23 502